Perspective Therapeutics, Inc. (CATX) Financial Statements (2026 and earlier)

Company Profile

Business Address 2401 ELLIOTT AVENUE
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:226,9009,23855,89063,8282,3925,326
Cash and cash equivalent61,5809,23855,89063,8282,3925,326
Short-term investments165,336     
Other undisclosed cash, cash equivalents, and short-term investments(16)     
Receivables6031,1751,6082,0132,0441,154
Inventory, net of allowances, customer advances and progress billings   1,396980645530
Inventory   1,396980645530
Prepaid expense1,4451,078391443382201
Disposal group, including discontinued operation  5,301    
Other current assets814527272727
Other undisclosed current assets2,131 17111777
Total current assets:231,16016,83759,32967,3025,5077,315
Noncurrent Assets
Inventory, Noncurrent   2,33376137155
Operating lease, right-of-use asset2,2157475127681,001✕
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization57,3215,5761,9761,9581,7351,609
Long-term investments and receivables126133    
Long-term investments126133    
Intangible asset, including goodwill, after accumulated amortization27924,416    
Goodwill  24,062    
Intangible asset, excluding goodwill, after accumulated amortization279354    
Restricted cash and investments  182182182181181
Other noncurrent assets405487107130138162
Other undisclosed noncurrent assets49,59549,513    
Total noncurrent assets:109,94181,0545,1103,1143,1922,107
TOTAL ASSETS:341,10197,89164,43970,4168,6999,422
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:10,3436,107966730654683
Employee-related liabilities✕✕✕ 259204142
Accrued liabilities5,478460    
Other undisclosed accounts payable and accrued liabilities4,8655,647966471450541
Deferred revenue 1,400    ✕
Debt5249    
Disposal group, including discontinued operation  5,072    
Other liabilities  4801201009474
Other undisclosed current liabilities6,4353,9561,180971827364
Total current liabilities:18,23015,6642,2661,8011,5751,121
Noncurrent Liabilities
Long-term debt and lease obligation1,6251,676256524769 
Long-term debt, excluding current maturities1,6251,676    
Liabilities, other than long-term debt30,5785,372640608577621
Deferred revenue26,600    ✕
Asset retirement obligations   640608577621
Deferred income tax liabilities2,4954,592   ✕
Other liabilities55     
Operating lease, liability1,428780256524769✕
Other undisclosed noncurrent liabilities    7755 
Total noncurrent liabilities:32,2037,0488961,2091,401621
Total liabilities:50,43322,7123,1623,0102,9761,742
Equity
Equity, attributable to parent290,66875,17961,27767,4065,7237,680
Common stock702821421426967
Additional paid in capital522,368227,337159,732158,58993,59292,105
Accumulated other comprehensive income (loss)(51)     
Accumulated deficit(231,719)(152,440)(98,597)(91,325)(87,938)(84,492)
Total equity:290,66875,17961,27767,4065,7237,680
TOTAL LIABILITIES AND EQUITY:341,10197,89164,43970,4168,6999,422

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Revenues  1,43410,79510,0539,6807,314
Cost of revenue
(Cost of Product and Service Sold)		  (298)(6,179)(4,932)(4,556)(4,267)
Other undisclosed gross profit  298    
Gross profit:  1,4344,6165,1215,1243,047
Operating expenses(92,340)(42,375)(12,007)(8,567)(8,600)(8,301)
Other undisclosed operating income1,454     
Operating loss:(90,886)(40,941)(7,391)(3,446)(3,476)(5,254)
Nonoperating income10,4598351195930110
Investment income, nonoperating10,5159341195930108
Other nonoperating income 2   2
Interest and debt expense  (84)    
Loss from continuing operations before equity method investments, income taxes:(80,427)(40,190)(7,272)(3,387)(3,446)(5,144)
Other undisclosed income from continuing operations before income taxes  84    
Loss from continuing operations before income taxes:(80,427)(40,106)(7,272)(3,387)(3,446)(5,144)
Income tax benefit2,0972,651    
Loss from continuing operations:(78,330)(37,455)(7,272)(3,387)(3,446)(5,144)
Loss before gain (loss) on sale of properties:✕✕✕(7,272)(3,387)(3,446)(5,144)
Income (loss) from discontinued operations(949)(9,053)    
Net loss attributable to parent:(79,279)(46,508)(7,272)(3,387)(3,446)(5,144)
Preferred stock dividends and other adjustments    (3)(11)(11)
Net loss available to common stockholders, diluted:(79,279)(46,508)(7,272)(3,390)(3,457)(5,155)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2025
12/31/2024
12/31/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Net loss:(79,279)(46,508)(7,272)(3,387)(3,446)(5,144)
Comprehensive loss:(79,279)(46,508)(7,272)(3,387)(3,446)(5,144)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(51)     
Comprehensive loss, net of tax, attributable to parent:(79,330)(46,508)(7,272)(3,387)(3,446)(5,144)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: